MedTrace Logo

Paced Electrogram Feature Analysis (PEFA) for Ablation Targeting in Ischaemic Ventricular Tachycardia

NCT03870854 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-11-15

No results posted yet for this study

Summary

Canadian multicentre prospective cohort study of 40 patients with ischaemic heart disease and therapy from an implantable cardioverter defibrillator (ICD).

Conditions

  • Ischemic Ventricular Tachycardia (VT)

Interventions

PROCEDURE

PEFA VT ablation technique

Catheter ablation guided by PEFA technique

Sponsors & Collaborators

  • Dr. Damian Redfearn

    lead OTHER

Principal Investigators

  • Damian Redfearn, MD · Queen's University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-13
Primary Completion
2024-08-30
Completion
2025-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03870854 on ClinicalTrials.gov